Skip to main content

Advertisement

Log in

A novel mutation of presenilin 1 in familial Alzheimer’s disease in Israel detected by denaturing gradient gel electrophoresis

  • Original investigation
  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

Germline mutations in the presenilin 1 (PS1) gene apparently account for the majority of early-onset, familial Alzheimer’s disease (AD). Using a mutation-screening strategy (denaturing gradient gel electrophoresis; DGGE), we analyzed a large family with early onset AD and seizures. The patients in this family showed a novel missense mutation in exon 5 of the PS1 gene (A to T change in codon 120, altering glutamine to aspartic acid). This novel mutation is located within the second hydrophilic domain of the molecule, a region not particularly involved in previously described germline mutations, and is of unknown biological significance. These results also demonstrate that DGGE can be used effectively to screen for mutations within this gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 3 July 1996 / Revised: 29 July 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reznik-Wolf, H., Treves, T., Davidson, M. et al. A novel mutation of presenilin 1 in familial Alzheimer’s disease in Israel detected by denaturing gradient gel electrophoresis. Hum Genet 98, 700–702 (1996). https://doi.org/10.1007/s004390050288

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004390050288

Keywords

Navigation